IMRX
USDImmuneering Corporation Class A Common Stock
$6.380+0.170 (2.738%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$6.210
最高
$6.730
最低
$6.150
交易量
0.05M
公司基本面
市值
403.5M
行業
生物科技
國家
United States
交易統計
平均交易量
1.87M
交易所
NGM
貨幣
USD
52週範圍
最低 $1.1當前 $6.380最高 $10.08
相關新聞
GlobeNewswire
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
- New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – - Conference call scheduled for Wednesday, November 12, 2025, at
查看更多
Analyst Upgrades
Leerink Partners Initiates Coverage On Immuneering with Outperform Rating, Announces Price Target of $15
Leerink Partners analyst Andrew Berens initiates coverage on Immuneering with a Outperform rating and announces Price Target of $15.
查看更多
